DEVELOPMENT OF A TRANSDERMAL MEDICINE FOR WOUND HEALING

Annotasiya

the relevance is due to the high prevalence of wound pathology and the lack of complex and effective means for its treatment in the domestic pharmaceutical market.

Manba turi: Jurnallar
Yildan beri qamrab olingan yillar 2021
inLibrary
Google Scholar
f
156
0

Кўчирилди

Кўчирилганлиги хақида маълумот йук.
Ulashish
Nikitin, K., & Zhilyakova , E. (2025). DEVELOPMENT OF A TRANSDERMAL MEDICINE FOR WOUND HEALING. Yevrosiyo Ilmiy Tadqiqotlar Jurnali, 5(10(MPHAPP), 156. Retrieved from https://inlibrary.uz/index.php/ejar/article/view/138286
0
Iqtibos
Crossref
Сrossref
Scopus
Scopus

Annotasiya

the relevance is due to the high prevalence of wound pathology and the lack of complex and effective means for its treatment in the domestic pharmaceutical market.


background image

156

Volume 5, Issue 10: Special Issue
(EJAR)

ISSN: 2181-2020

MPHAPP

THE 6TH INTERNATIONAL SCIENTIFIC AND PRACTICAL
CONFERENCE

MODERN PHARMACEUTICS: ACTUAL

PROBLEMS AND PROSPECTS

TASHKENT, OCTOBER 17, 2025

in-academy.uz

DEVELOPMENT OF A TRANSDERMAL MEDICINE FOR WOUND HEALING

Nikitin K.A.

Zhilyakova E.T.

Belgorod State National Research University, Belgorod, Russian Federation

e-mail: sovelij7478@gmail.com, phone +79087895220

https://doi.org/10.5281/zenodo.17328605

Relevance:

the relevance is due to the high prevalence of wound pathology and the lack of

complex and effective means for its treatment in the domestic pharmaceutical market.

Purpose of the study:

development of a transdermal dosage form of wound healing action

Materials and methods:

analytical research methods and computer modeling methods were

used in the work

Results:

in order to reduce the development time and material costs, 8 compositions containing

benzyl dimethyl[3-(myristoyl amino) as an antimicrobial component were selected using the Syntelly
artificial intelligence platform for organic and medical chemistry.propyl]ammonium (miramistin),
xymedon, or acecsamic acid as a reparant, as well as 1 of 5 NSAIDs: ketoprofen, ketorolac,
benzydamine, nimesulide, or phenylbutazone, which are predicted to be stable. Three design options
for a transdermal system have been proposed to provide controlled prolonged release. (pict.1).

Picture 1.

Schemes of proposed designs of transdermal therapeutic systems with wound-

healing effect: matrix (A), reservoir (B), and combined (C).

Conclusions:

possible compositions and designs of a transdermal therapeutic system have been

developed and theoretically substantiated.

А

1 -

Подложка

Б

1 -

Подложка

2 –

Адгезив с растворенным ЛВ

2 -

Резервуар с растворенным ЛВ

3 –

Защитная пленка

3 -

Мембрана

4 -

Адгезив

5

- Защитная пленка

В 1 -

Подложка

2 -

Резервуар с растворенным ЛВ

3 -

Мембрана

4 -

Адгезив с растворенным ЛВ

5

- Защитная пленка